Ignite Creation Date:
2024-05-05 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00000801
Status:
COMPLETED
Last Update Posted:
2012-11-01
First Post:
1999-11-02
Brief Title:
Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Conditions & Keywords Data
Conditions:
| Name |
|---|
| HIV Infections |
| Lymphoma Non-Hodgkin |
Keywords:
| Name | View |
|---|---|
| Lymphoma Intermediate-Grade | View |
| Vincristine | View |
| Cyclophosphamide | View |
| Cytarabine | View |
| Dexamethasone | View |
| Doxorubicin | View |
| Granulocyte Colony-Stimulating Factor | View |
| Combined Modality Therapy | View |
| Acquired Immunodeficiency Syndrome | View |
| Antineoplastic Agents Combined | View |
| Brain Neoplasms | View |
| Lymphoma High-Grade | View |